{"id":12563,"date":"2026-04-10T16:08:40","date_gmt":"2026-04-10T07:08:40","guid":{"rendered":"https:\/\/miragen.clinic\/blog\/should-you-use-tofacitinib-ointment-via-direct-purchase-what-clinical-evidence-says\/"},"modified":"2026-07-02T00:39:16","modified_gmt":"2026-07-01T15:39:16","slug":"should-you-use-tofacitinib-ointment-via-direct-purchase-what-clinical-evidence-says","status":"publish","type":"post","link":"https:\/\/miragen.clinic\/en\/blog\/should-you-use-tofacitinib-ointment-via-direct-purchase-what-clinical-evidence-says\/","title":{"rendered":"Should You Use Tofacitinib Ointment via Direct Purchase? | What Clinical Evidence Says"},"content":{"rendered":"\n
\n
\n

Recently, Tofatas, a tofacitinib ointment<\/strong>, has become a hot topic in atopic dermatitis communities. Reviews are spreading rapidly, claiming it is a “steroid-free ointment with amazing effects” and that it can be “purchased directly from India.” <\/p>\n\n\n\n

In fact, I have often seen patients in the clinic who are already using tofacitinib ointment through direct purchase, so I thought it would be helpful to summarize the details.<\/p>\n\n\n\n

Item<\/th>Tofacitinib Ointment 2%<\/th>Elidel 1%<\/th>Protopic 0.1%<\/th><\/tr><\/thead>
Ingredients<\/td>Tofacitinib (JAK 1\/3 inhibitor)<\/td>Pimecrolimus (Calcineurin inhibitor)<\/td>Tacrolimus (Calcineurin inhibitor)<\/td><\/tr>
Efficacy Level<\/td>Equivalent to Elidel (Based on Phase 3 clinical trials)<\/td>Lower than Protopic<\/td>Most potent<\/td><\/tr>
Approval in Korea<\/td>Not approved<\/td>Approved (Insurance covered)<\/td>Approved (Insurance covered)<\/td><\/tr>
Purchase Method<\/td>Direct purchase from India<\/td>Prescription<\/td>Prescription<\/td><\/tr>
Cost (Based on 30g)<\/td>Approx. 50,000 KRW (Purchase + Shipping)<\/td>Approx. 20,000 KRW<\/td>Approx. 20,000 KRW<\/td><\/tr>
Formulation \u00b7 Texture<\/td>Ointment (Sticky)<\/td>Cream (Lightweight)<\/td>Ointment (Sticky)<\/td><\/tr>
Pore Clogging (Acne-inducing)<\/td>Present<\/td>Low<\/td>Present<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n\n\n\n

\ubaa9\ucc28<\/h2>